These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 1963129)
1. Variations in breast cancer treatment decisions and their impact in mounting trials. Deber RB; Thompson GG Control Clin Trials; 1990 Oct; 11(5):353-73. PubMed ID: 1963129 [TBL] [Abstract][Full Text] [Related]
2. Patient and physician attitudes toward breast cancer clinical trials: developing interventions based on understanding barriers. Melisko ME; Hassin F; Metzroth L; Moore DH; Brown B; Patel K; Rugo HS; Tripathy D Clin Breast Cancer; 2005 Apr; 6(1):45-54. PubMed ID: 15899072 [TBL] [Abstract][Full Text] [Related]
3. Decision Aids Can Support Cancer Clinical Trials Decisions: Results of a Randomized Trial. Politi MC; Kuzemchak MD; Kaphingst KA; Perkins H; Liu J; Byrne MM Oncologist; 2016 Dec; 21(12):1461-1470. PubMed ID: 27511904 [TBL] [Abstract][Full Text] [Related]
4. Overconfidence among physicians and nurses: the 'micro-certainty, macro-uncertainty' phenomenon. Baumann AO; Deber RB; Thompson GG Soc Sci Med; 1991; 32(2):167-74. PubMed ID: 2014413 [TBL] [Abstract][Full Text] [Related]
6. Barriers to participation in randomized clinical trials for early breast cancer among Australian cancer specialists. Ellis PM; Butow PN; Simes RJ; Tattersall MH; Dunn SM Aust N Z J Surg; 1999 Jul; 69(7):486-91. PubMed ID: 10442918 [TBL] [Abstract][Full Text] [Related]
7. Understanding the decisions of cancer clinical trial participants to enter research studies: factors associated with informed consent, patient satisfaction, and decisional regret. Stryker JE; Wray RJ; Emmons KM; Winer E; Demetri G Patient Educ Couns; 2006 Oct; 63(1-2):104-9. PubMed ID: 16242898 [TBL] [Abstract][Full Text] [Related]
8. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000. National Institutes of Health Consensus Development Panel J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285 [TBL] [Abstract][Full Text] [Related]
9. The choice is yours? How women with ovarian cancer make sense of treatment choices. Ziebland S; Evans J; McPherson A Patient Educ Couns; 2006 Sep; 62(3):361-7. PubMed ID: 16876377 [TBL] [Abstract][Full Text] [Related]
10. Decision-making and breast cancer clinical trials: how experience challenges attitudes. Mancini J; Genève J; Dalenc F; Genre D; Monnier A; Kerbrat P; Largillier R; Serin D; Rios M; Roché H; Jimenez M; Tarpin C; ; Julian Reynier C Contemp Clin Trials; 2007 Nov; 28(6):684-94. PubMed ID: 17434812 [TBL] [Abstract][Full Text] [Related]
11. Doctor-patient communication about breast cancer adjuvant therapy. Siminoff LA; Fetting JH; Abeloff MD J Clin Oncol; 1989 Sep; 7(9):1192-200. PubMed ID: 2671280 [TBL] [Abstract][Full Text] [Related]
12. Who still prefers aggressive surgery for breast cancer? Implications for the clinical applications of clinical trials. Deber RB; Thompson GG Arch Intern Med; 1987 Sep; 147(9):1543-7. PubMed ID: 3307671 [TBL] [Abstract][Full Text] [Related]
13. Tailoring and evaluating an intervention to improve shared decision-making among seniors with dementia, their caregivers, and healthcare providers: study protocol for a randomized controlled trial. Giguere AMC; Lawani MA; Fortier-Brochu É; Carmichael PH; Légaré F; Kröger E; Witteman HO; Voyer P; Caron D; Rodríguez C Trials; 2018 Jun; 19(1):332. PubMed ID: 29941020 [TBL] [Abstract][Full Text] [Related]
14. Willingness of breast cancer patients to undergo biopsy and breast cancer clinicians' practices around seeking biopsy at the time of breast cancer relapse. Lohrisch C; Francl M; Sun S; Villa D; Gelmon KA Breast Cancer Res Treat; 2018 Feb; 168(1):221-228. PubMed ID: 29181718 [TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy in elderly women with breast cancer: patients' perspectives on information giving and decision making. Harder H; Ballinger R; Langridge C; Ring A; Fallowfield LJ Psychooncology; 2013 Dec; 22(12):2729-35. PubMed ID: 23813806 [TBL] [Abstract][Full Text] [Related]
16. Communication about standard treatment options and clinical trials: can we teach doctors new skills to improve patient outcomes? Bernhard J; Butow P; Aldridge J; Juraskova I; Ribi K; Brown R Psychooncology; 2012 Dec; 21(12):1265-74. PubMed ID: 23208837 [TBL] [Abstract][Full Text] [Related]
17. Physicians' opinions about decision aids for patients considering systemic adjuvant therapy for axillary-node negative breast cancer. O'Connor AM; Llewellyn-Thomas HA; Sawka C; Pinfold SP; To T; Harrison DE Patient Educ Couns; 1997 Feb; 30(2):143-53. PubMed ID: 9128616 [TBL] [Abstract][Full Text] [Related]
18. Cancer prevention trials and primary care physicians: factors associated with recommending trial enrollment. Battaglia TA; Ash A; Prout MN; Freund KM Cancer Detect Prev; 2006; 30(1):34-7. PubMed ID: 16476525 [TBL] [Abstract][Full Text] [Related]
19. Current and future management of "early" breast cancer: attitude survey amongst participants in cancer research campaign trial. Baum M; Houghton J Lancet; 1980 Apr; 1(8174):929. PubMed ID: 6103276 [No Abstract] [Full Text] [Related]
20. Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate. Ellis PM; Butow PN; Tattersall MH; Dunn SM; Houssami N J Clin Oncol; 2001 Aug; 19(15):3554-61. PubMed ID: 11481363 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]